HomeBNTX • NASDAQ
add
BioNTech
$119.75
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$119.75
Sarado: Ene 27, 4:02:00 PM GMT-5 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$118.14
Sakop ng araw
$118.01 - $121.34
Sakop ng taon
$76.53 - $131.49
Market cap
28.71B USD
Average na Volume
673.46K
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.24B | 39.04% |
Gastos sa pagpapatakbo | 1.04B | 53.43% |
Net na kita | 198.10M | 23.35% |
Net profit margin | 15.91 | -11.32% |
Kita sa bawat share | 0.81 | 20.90% |
EBITDA | 65.30M | -30.31% |
Aktuwal na % ng binabayarang buwis | -24.83% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 16.71B | 6.10% |
Kabuuang asset | 22.40B | 0.87% |
Kabuuang sagutin | 3.29B | 40.43% |
Kabuuang equity | 19.11B | — |
Natitirang share | 239.74M | — |
Presyo para makapag-book | 1.48 | — |
Return on assets | 0.23% | — |
Return on capital | 0.27% | — |
Cash Flow
Net change in cash
| (EUR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 198.10M | 23.35% |
Cash mula sa mga operasyon | -638.90M | -178.76% |
Cash mula sa pag-invest | -142.10M | 88.47% |
Cash mula sa financing | -7.90M | 97.46% |
Net change in cash | -752.10M | -12.12% |
Malayang cash flow | -684.45M | -217.91% |
Tungkol
BioNTech SE is a global biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
The company utilizes technology platforms including mRNA-based therapies, targeted therapies, and immunomodulators, to develop its treatments. BioNTech's pipeline includes several late-stage programs in oncology testing combination therapy approaches to improve treatment outcomes.
In the field of infectious diseases, BioNTech, partnering with Pfizer, developed Comirnaty, the first approved mRNA-based vaccine, which was widely used during the COVID-19 pandemic. Wikipedia
CEO
Itinatag
2008
Website
Mga Empleyado
6,133
